You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
11 July 2015
FDA approves Rexulti (brexpiprazole) as adjunctive treatment for adults with major depressive disorder and as a treatment for adults with schizophrenia
23 June 2015
Young adult patients* with schizophrenia show improved functioning and health-related quality of life with Abilify Maintena® (aripiprazole once-monthly) compared with paliperidone palmitate
14 June 2015
Major shareholder announcement
2 June 2015
Total number of voting rights and share capital in H. Lundbeck A/S as of 31 May 2015
21 May 2015
Lundbeck increases its share capital by 186,676 shares (0.0950% of outstanding shares)
6 May 2015
Solid performance in the first quarter of the year. Full year guidance maintained